Media coverage
17
Media coverage
Title Voyager Therapeutics to Present Preclinical Data from its Vectorized anti-HER2 Antibody Program and a Novel AAV5-Derived TRACER™ Capsid at the 25th American Society of Gene and Cell Therapy Annual Meeting Media name/outlet Morningstar.com Country/Territory United States Date 16/05/22 URL https://www.morningstar.com/news/globe-newswire/8542748/voyager-therapeutics-to-present-preclinical-data-from-its-vectorized-anti-her2-antibody-program-and-a-novel-aav5-derived-tracer-capsid-at-the-25th-american-society-of-gene-and-cell-therapy-annual-meeting Persons Mathieu Nonnenmacher Title Voyager Therapeutics to Present Preclinical Data from its Vectorized anti-HER2 Antibody Program and a Novel AAV5-Derived TRACER™ Capsid at the 25th American Society of Gene and Cell Therapy Annual M Media name/outlet Street Insider Country/Territory United States Date 16/05/22 URL https://www.streetinsider.com/Press+Releases/Voyager+Therapeutics+to+Present+Preclinical+Data+from+its+Vectorized+anti-HER2+Antibody+Program+and+a+Novel+AAV5-Derived+TRACER%E2%84%A2+Capsid+at+the+25th+American+Society+of+Gene+and+Cell+Therapy+Annual+M/20076412.html Persons Mathieu Nonnenmacher Title Voyager Therapeutics to Present Preclinical Data from its Vectorized anti-HER2 Antibody Program and a Novel AAV5-Derived TRACER™ Capsid at the 25th American Society of Gene and Cell Therapy Annual Meeting Media name/outlet TMC Net Country/Territory United States Date 16/05/22 URL https://technews.tmcnet.com/news/2022/05/16/9602170.htm Persons Mathieu Nonnenmacher Title Voyager Therapeutics to Present Preclinical Data from its … Media name/outlet TMC Net Country/Territory United States Date 16/05/22 URL https://www.tmcnet.com/usubmit/-voyager-therapeutics-present-preclinical-data-from-its-vectorized-/2022/05/16/9602170.htm Persons Mathieu Nonnenmacher Title Voyager Therapeutics to Present Preclinical Data from its Vectorized anti-HER2 Antibody Program and a Novel AAV5-Derived TRACER™ Capsid at the 25th American Society of Gene and Cell Therapy Annual Meeting Media name/outlet BioSpace Country/Territory United States Date 16/05/22 URL https://www.biospace.com/article/releases/voyager-therapeutics-to-present-preclinical-data-from-its-vectorized-anti-her2-antibody-program-and-a-novel-aav5-derived-tracer-capsid-at-the-25th-american-society-of-gene-and-cell-therapy-annual-meeting/?s=73 Persons Mathieu Nonnenmacher Title Voyager Therapeutics to Present Preclinical Data from its Vectorized anti-HER2 Antibody Program and a Novel AAV5-Derived TRACER™ Capsid at the 25th American Society of Gene and Cell Therapy Annual Meeting Media name/outlet ADVFN UK Country/Territory United Kingdom Date 16/05/22 URL https://uk.advfn.com/stock-market/NASDAQ/VYGR/share-news/Voyager-Therapeutics-to-Present-Preclinical-Data-f/88116305 Persons Mathieu Nonnenmacher Title Voyager Therapeutics to Present Preclinical Data from its Vectorized anti-HER2 Antibody Program and a Novel AAV5-Derived TRACER™ Capsid at the 25th American Society of Gene and Cell Therapy Annual Meeting Media name/outlet Yahoo! Canada Country/Territory Canada Date 16/05/22 URL https://ca.sports.yahoo.com/news/voyager-therapeutics-present-preclinical-data-100000205.html?src=rss Persons Mathieu Nonnenmacher Title Voyager Therapeutics to Present Preclinical Data from its Vectorized anti-HER2 Antibody Program and a Novel AAV5-Derived TRACER™ Capsid at the 25th American Society of Gene and Cell Therapy Annual Meeting Media name/outlet Yahoo! Finance Country/Territory United States Date 16/05/22 URL https://finance.yahoo.com/news/voyager-therapeutics-present-preclinical-data-100000205.html Persons Mathieu Nonnenmacher Title Voyager Therapeutics to Present Preclinical Data from its Vectorized anti-HER2 Antibody Program and a Novel AAV5-Derived TRACER™ Capsid at the 25th American Society of Gene and Cell Therapy Annual Meeting Media name/outlet MarketScreener.com Country/Territory United States Date 16/05/22 URL https://www.marketscreener.com/quote/stock/VOYAGER-THERAPEUTICS-INC-24872703/news/Voyager-Therapeutics-to-Present-Preclinical-Data-from-its-Vectorized-anti-HER2-Antibody-Program-and-40441142/ Persons Mathieu Nonnenmacher Title Voyager Therapeutics to Present Preclinical Data from its Vectorized anti-HER2 Antibody Program and a Novel AAV5-Derived TRACER(TM) Capsid at the 25th American Society of Gene and Cell Therapy Annual Meeting Media name/outlet Stockwatch Country/Territory Canada Date 16/05/22 URL www.stockwatch.com/News/Item/U-z8542748-U!VYGR-20220516/U/VYGR Persons Mathieu Nonnenmacher Title Voyager Therapeutics to Present Preclinical Data from its Vectorized anti-HER2 Antibody Program and a Novel AAV5-Derived TRACER™ Capsid at the 25th American Society of Gene and Cell Therapy Annual Meeting Media name/outlet Market Newsdesk Country/Territory United States Date 16/05/22 URL https://www.marketnewsdesk.com/index.php/voyager-therapeutics-to-present-preclinical-data-from-its-vectorized-anti-her2-antibody-program-and-a-novel-aav5-derived-tracer-capsid-at-the-25th-american-society-of-gene-and-cell-therapy-an/ Persons Mathieu Nonnenmacher Title Voyager Therapeutics to Present Preclinical Data from its Vectorized anti-HER2 Antibody Program and a Novel AAV5-Derived TRACER™ Capsid at the 25th American Society of Gene and Cell Therapy Annual Meeting Media name/outlet ADVFN US Country/Territory United States Date 16/05/22 URL https://www.advfn.com/p.php?pid=nmona&article=88116305 Persons Mathieu Nonnenmacher Title To Present Preclinical Data from its Vectorized anti HER2 Antibody Program and a Novel AAV5 Derived TRACER Capsid at the 25th American Society of Gene and Cell Therapy Annual Meeting Media name/outlet Market News Publishing Country/Territory United States Date 16/05/22 Persons Mathieu Nonnenmacher Title Voyager Therapeutics to Present Preclinical Data from its Vectorized anti-HER2 Antibody Program and a Novel AAV5-Derived TRACER™ Capsid at the 25th American Society of Gene and Cell Therapy Annual Meeting Media name/outlet GlobeNewswire Country/Territory United States Date 16/05/22 URL https://www.globenewswire.com/news-release/2022/05/16/2443568/36461/en/Voyager-Therapeutics-to-Present-Preclinical-Data-from-its-Vectorized-anti-HER2-Antibody-Program-and-a-Novel-AAV5-Derived-TRACER-Capsid-at-the-25th-American-Society-of-Gene-and-Cell.html Persons Mathieu Nonnenmacher Title Voyager Therapeutics to Present Preclinical Data from its Vectorized anti-HER2 Antibody Program and a Novel AAV5-Derived TRACER™ Capsid at the 25th American Society of Gene and Cell Therapy Annual Meeting Media name/outlet PrimeNewswire (Top News) Country/Territory United States Date 16/05/22 Persons Mathieu Nonnenmacher Title Voyager Therapeutics to Present Preclinical Data from its Vectorized anti-HER2 Antibody Program and a Novel AAV5-Derived TRACER™ Capsid at the 25th American Society of Gene and Cell Therapy Annual Meeting Media name/outlet BizWire Express Country/Territory India Date 16/05/22 URL www.bizwireexpress.com/showstoryGNW.php?storyid=394789 Persons Mathieu Nonnenmacher Title Voyager Therapeutics To Present Preclinical Data From Its Vectorized Anti-HER2 Antibody Program And A Novel AAV5-Derived TRACER Capsid At The 25Th American Society Of Gene And Cell Therapy Annual Meeting Media name/outlet MENAFN -Press Releases (English) Country/Territory Jordan Date 16/05/22 Persons Mathieu Nonnenmacher